Pre-clinical study of IRDye800CWnimotuzumab formulation, stability, pharmacokinetics, and safety

Epidermal growth factor receptor (EGFR) is a target for cancer therapy as it is overexpressed in a wide variety of cancers. Therapeutic antibodies that bind EGFR are being evaluated in clinical trials as imaging agents for positron emission tomography and image-guided surgery.